FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21967511000001101: Constella 290microgram capsules (AbbVie Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Mar 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2217061000001111 Constella 290microgram capsules (AbbVie Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2217071000001118 Constella 290microgram capsules (AbbVie Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Constella 290microgram capsules (AbbVie Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Is a Linaclotide 290microgram capsules true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has specific active ingredient Linaclotide false Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Is a Constella true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has specific active ingredient Linaclotide true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has active ingredient Linaclotide true Inferred relationship Existential restriction modifier
Constella 290microgram capsules (AbbVie Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Constella 290microgram capsules (AbbVie Ltd) 28 capsule Has AMP True Constella 290microgram capsules (AbbVie Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start